ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors and Board committees. The Board includes both executive and non-executive Directors, alongside independent non-executive Directors. Additionally, the company outlined the members and chairpersons of its three main Board committees: Audit, Remuneration, and Nomination.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.
